Michael Bohm

Summary

Affiliation: Saarland University
Country: Germany

Publications

  1. ncbi Treatment of heart failure with beta-blockers. Mechanisms and results
    M Bohm
    Medizinische Klinik und Poliklinik der Universität des Saarlandes, Innere Medizin III, Homburg Saar, Germany
    Basic Res Cardiol 95:I15-24. 2000
  2. ncbi [The "French Paradox"--effects of alcohol, wine and wine polyphenols on the heart]
    M Bohm
    Medizinische Universitätsklinik und Poliklinik, Innere Medizin III, Kardiologie Angiologie, Homburg Saar, Germany
    Dtsch Med Wochenschr 127:2748-56. 2002
  3. ncbi [Indications for renal angiography and for percutaneous transluminal renal artery dilatation: interdisciplinary consensus statement regarding renal artery stenosis]
    M Bohm
    Medizinische Universitätsklinik und Poliklinik, Innere Medizin III, Kardiologie, Universitatskliniken des Saarlandes, Homburg Saar
    Dtsch Med Wochenschr 128:150-6. 2003
  4. ncbi Does statin therapy influence steroid hormone synthesis?
    M Bohm
    Klinik fur Innere Medizin III, Universitatskliniken des Saarlandes, Kirrberger Strasse, 66421 Homburg, Germany
    Z Kardiol 93:43-8. 2004
  5. ncbi Perspectives of I(f) inhibition by ivabradine in cardiology
    Michael Bohm
    Klinik für Innere Medizin III Kardiologie Angiologie Internistische Intensivmedizin, Universitatsklinikum des Saarlandes, Homburg Saar, Germany
    Drugs 67:43-9. 2007
  6. ncbi Sexual function, satisfaction, and association of erectile dysfunction with cardiovascular disease and risk factors in cardiovascular high-risk patients: substudy of the ONgoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telm
    Michael Bohm
    Klinik für Innere Medizin III des Universitätsklinikum des Saarlandes, Saarland, Homburg, Germany
    Am Heart J 154:94-101. 2007
  7. ncbi [Drug treatment of chronic heart failure]
    M Bohm
    Universitatsklinikum des Saarlandes, Klinik fur Innere Medizin III, Homburg Saar
    Clin Res Cardiol 95:36-54; quiz 55-6. 2006
  8. ncbi Heart failure and statins--why do we need a clinical trial?
    M Bohm
    Klinik fur Innere Medizin III, Universitätsklinik des Saarlandes, Kirrberger Strasse, 66421 Homburg, Gemany
    Z Kardiol 94:223-30. 2005
  9. ncbi Alcohol and red wine: impact on cardiovascular risk
    Michael Bohm
    Medizinische Universitätsklinik und Poliklinik, Innere Medizin III, Kardiologie Angiologie, Kirrberger Strasse, D 66421 Homburg Saar, Germany
    Nephrol Dial Transplant 19:11-6. 2004
  10. ncbi [ACE-inhibitor effects on the stabilization of coronary heart disease. EUROPA study]
    M Bohm
    Klinik fur Innere Medizin III, Universitatsklinikum, Homburg Saar
    Internist (Berl) 45:1196-8. 2004

Collaborators

Detail Information

Publications116 found, 100 shown here

  1. ncbi Treatment of heart failure with beta-blockers. Mechanisms and results
    M Bohm
    Medizinische Klinik und Poliklinik der Universität des Saarlandes, Innere Medizin III, Homburg Saar, Germany
    Basic Res Cardiol 95:I15-24. 2000
    ..The mechanism of beta-blocker effects in heart failure are cardiac protection from beta1-adrenoceptor overstimulation, antiarrhythmic effects, reduction in heart rate and positive energetic effects or a combination thereof...
  2. ncbi [The "French Paradox"--effects of alcohol, wine and wine polyphenols on the heart]
    M Bohm
    Medizinische Universitätsklinik und Poliklinik, Innere Medizin III, Kardiologie Angiologie, Homburg Saar, Germany
    Dtsch Med Wochenschr 127:2748-56. 2002
  3. ncbi [Indications for renal angiography and for percutaneous transluminal renal artery dilatation: interdisciplinary consensus statement regarding renal artery stenosis]
    M Bohm
    Medizinische Universitätsklinik und Poliklinik, Innere Medizin III, Kardiologie, Universitatskliniken des Saarlandes, Homburg Saar
    Dtsch Med Wochenschr 128:150-6. 2003
  4. ncbi Does statin therapy influence steroid hormone synthesis?
    M Bohm
    Klinik fur Innere Medizin III, Universitatskliniken des Saarlandes, Kirrberger Strasse, 66421 Homburg, Germany
    Z Kardiol 93:43-8. 2004
    ..There was no compensatory change in FSH or LH. It is concluded that pravastatin does not alter steroid hormones or gonadotropins in a clinically applicable dose, which significantly reduces total and LDL cholesterol...
  5. ncbi Perspectives of I(f) inhibition by ivabradine in cardiology
    Michael Bohm
    Klinik für Innere Medizin III Kardiologie Angiologie Internistische Intensivmedizin, Universitatsklinikum des Saarlandes, Homburg Saar, Germany
    Drugs 67:43-9. 2007
    ..Further clinical and mechanistic studies to clarify the pathophysiological background are needed to fully define the role of heart rate reduction in the broad spectrum of cardiovascular interventions...
  6. ncbi Sexual function, satisfaction, and association of erectile dysfunction with cardiovascular disease and risk factors in cardiovascular high-risk patients: substudy of the ONgoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telm
    Michael Bohm
    Klinik für Innere Medizin III des Universitätsklinikum des Saarlandes, Saarland, Homburg, Germany
    Am Heart J 154:94-101. 2007
    ..The effects of treatment with telmisartan and ramipril, alone or in combination, including a telmisartan versus placebo arm will be determined prospectively during a follow-up of 4 years...
  7. ncbi [Drug treatment of chronic heart failure]
    M Bohm
    Universitatsklinikum des Saarlandes, Klinik fur Innere Medizin III, Homburg Saar
    Clin Res Cardiol 95:36-54; quiz 55-6. 2006
    ..Treatment has to be adjusted to current guidelines. The state of the art of medical treatment of chronic heart failure is addressed in this report...
  8. ncbi Heart failure and statins--why do we need a clinical trial?
    M Bohm
    Klinik fur Innere Medizin III, Universitätsklinik des Saarlandes, Kirrberger Strasse, 66421 Homburg, Gemany
    Z Kardiol 94:223-30. 2005
    ..Since there are no safety data on the use of statins in chronic heart failure, a controlled randomized and placebo-controlled trial is urgently needed...
  9. ncbi Alcohol and red wine: impact on cardiovascular risk
    Michael Bohm
    Medizinische Universitätsklinik und Poliklinik, Innere Medizin III, Kardiologie Angiologie, Kirrberger Strasse, D 66421 Homburg Saar, Germany
    Nephrol Dial Transplant 19:11-6. 2004
  10. ncbi [ACE-inhibitor effects on the stabilization of coronary heart disease. EUROPA study]
    M Bohm
    Klinik fur Innere Medizin III, Universitatsklinikum, Homburg Saar
    Internist (Berl) 45:1196-8. 2004
  11. ncbi Effect of bisoprolol on perioperative complications in chronic heart failure after surgery (Cardiac Insufficiency Bisoprolol Study II (CIBIS II))
    M Bohm
    Universitatskliniken des Saarlandes, Medizinische Klinik und Poliklinik, Innere Medizin III, 66421 Homburg Saar, Germany
    Z Kardiol 92:668-76. 2003
    ..Therefore, a controlled randomized trial with perioperative beta-blocker treatment in heart failure patients is warranted to further test this hypothesis...
  12. ncbi [Pathophysiology of heart failure today]
    Michael Bohm
    Medizinische Universitätsklinik und Poliklinik, Innere Medizin III, Homburg Saar
    Herz 27:75-91. 2002
    ..The characterization of the underlying mechanisms can offer potential new strategies of the treatment of these malignant condition...
  13. ncbi Heart rate reduction with ivabradine improves erectile dysfunction in parallel to decrease in atherosclerotic plaque load in ApoE-knockout mice
    Magnus Baumhakel
    Klinik fur Innere Medizin III, Universitatsklinikum des Saarlandes, D 66421 Homburg Saar, Germany
    Atherosclerosis 212:55-62. 2010
    ..To determine the effect of heart rate reduction with ivabradine on atherosclerotic lesions and erectile dysfunction...
  14. ncbi Role of Rac1 GTPase activation in atrial fibrillation
    Oliver Adam
    Klinik fur Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Universitatsklinikum des Saarlandes, Homburg Saar, Germany
    J Am Coll Cardiol 50:359-67. 2007
    ..We aimed to study the role of Rac1 GTPase in atrial fibrillation (AF)...
  15. ncbi Improvement of endothelial function of the corpus cavernosum in apolipoprotein E knockout mice treated with irbesartan
    Magnus Baumhakel
    Klinik fur Innere Medizin III, Kardiologie, Angiologie, und Internistische Intensivmedizin, Universitatsklinikum des Saarlandes, Homburg Saar, Germany
    J Pharmacol Exp Ther 327:692-8. 2008
    ..This result emphasizes the beneficial effect of inhibition of the renin-angiotensin system even in terms of erectile function...
  16. ncbi Effects of diuretic treatment on cardiac and circulating RAS in chronic heart failure post-myocardial infarction in rats
    Ute Seeland
    Innere Medizin III, Kardiologie und Angiologie, Med Klinik und Poliklinik der Universität des Saarlandes, 66421 Homburg Saar, Germany
    Eur J Heart Fail 5:241-6. 2003
    ..Heart failure is often treated with ACE inhibitors and diuretics although diuretic treatment could activate the renin-angiotensin system (RAS)...
  17. ncbi Long-term follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter
    Bruno Scheller
    Klinik fur Innere Medizin, III, Universitatsklinikum des Saarlandes, Homburg Saar, Germany
    JACC Cardiovasc Interv 5:323-30. 2012
    ..This study presents long-term clinical follow-up, including binary restenosis rate and major adverse cardiovascular events, of the PACCOCATH-ISR (Treatment of In-Stent Restenosis by Paclitaxel Coated PTCA Balloons) I and II trial...
  18. ncbi Paclitaxel and sirolimus differentially affect growth and motility of endothelial progenitor cells and coronary artery smooth muscle cells
    Yvonne P Clever
    Klinik fur Innere Medizin III, Universitatsklinikum des Saarlandes, Homburg Saar, Germany
    EuroIntervention 7:K32-42. 2011
    ..This study investigates the time-dependent influence on growth and motility of paclitaxel and sirolimus alone and combined with the coating additive iopromide on EPC and hCASMC...
  19. ncbi [Update cardiology 2001/2002-part II. From unstable coronary syndrome to terminal heart failure]
    Roland Fries
    Medizinische Klinik und Poliklinik, Innere Medizin III Kardiologie Angiologie, Universitatskliniken des Saarlandes, Hamburg Saar
    Med Klin (Munich) 98:326-34. 2003
    ....
  20. ncbi Differential effects on inhibition of cholesterol absorption by plant stanol and plant sterol esters in apoE-/- mice
    Oliver Weingärtner
    Klinik fur Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Universitatsklinikum des Saarlandes, Kirrberger Strasse, Gebäude 40, 66421 Homburg Saar, Germany
    Cardiovasc Res 90:484-92. 2011
    ..However, their effects on blood monocytes, endothelial function, atherogenesis, and sterol tissue concentrations are poorly understood...
  21. ncbi Pioglitazone activates aortic telomerase and prevents stress-induced endothelial apoptosis
    Christian Werner
    Klinik fur Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Universitatsklinikum des Saarlandes, 66421 Homburg, Saar, Germany
    Atherosclerosis 216:23-34. 2011
    ..PPAR-γ agonists may mediate vascular effects in addition to insulin sensitizing. We therefore examined whether pioglitazone regulates vascular telomere biology...
  22. ncbi Physical exercise prevents cellular senescence in circulating leukocytes and in the vessel wall
    Christian Werner
    Klinik fur Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Universitatsklinikum des Saarlandes, 66421 Homburg Saar, Germany
    Circulation 120:2438-47. 2009
    ..This study examines the effects of exercising on vascular telomere biology and endothelial apoptosis in mice and the effects of long-term endurance training on telomere biology in humans...
  23. ncbi ACE inhibition promotes upregulation of endothelial progenitor cells and neoangiogenesis in cardiac pressure overload
    Patrick Muller
    Klinik fur Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Universitatsklinikum des Saarlandes, Homburg Saar, Germany
    Cardiovasc Res 83:106-14. 2009
    ..We hypothesized that ACE inhibitors may exert beneficial effects during pressure-induced myocardial hypertrophy by regulating progenitor cell function...
  24. ncbi Cardiac Rac1 overexpression in mice creates a substrate for atrial arrhythmias characterized by structural remodelling
    Jan Christian Reil
    Klinik für Innere Medizin III Kardiologie, Angiologie, Internistische Intensivmedizin, Universitatsklinikum des Saarlandes, Kirrberger Strasse, Homburg Saar D 66421, Germany
    Cardiovasc Res 87:485-93. 2010
    ..The small GTPase Rac1 seems to play a role in the pathogenesis of atrial fibrillation (AF). The aim of the present study was to characterize the effects of Rac1 overexpression on atrial electrophysiology...
  25. ncbi Drug-eluting balloon: very short-term exposure and overlapping
    Bodo Cremers
    University of Saarland, Homburg Saar, Department of Internal Medicine III, Germany
    Thromb Haemost 101:201-6. 2009
    ..DEB were found to effectively reduce neointimal proliferation regardless of inflation time and dose within the tested range. No adverse reactions were seen as dose was increased to more than three times the clinically tested dose...
  26. ncbi Markers of enhanced cholesterol absorption are a strong predictor for cardiovascular diseases in patients without diabetes mellitus
    Oliver Weingärtner
    Klinik fur Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Universitatsklinikum des Saarlandes, Homburg, Saar, Germany
    Chem Phys Lipids 164:451-6. 2011
    ..The aim of the present study was to evaluate markers of cholesterol metabolism and determine their relationship with CVD in patients without diabetes mellitus who were not receiving statin treatment...
  27. ncbi Contrast media as carriers for local drug delivery. Successful inhibition of neointimal proliferation in the porcine coronary stent model
    Bruno Scheller
    Internal Medicine III, University of Saarland, D 66421 Homburg Saar, Germany
    Eur Heart J 24:1462-7. 2003
    ..The aim of this study was to test a novel taxane-contrast agent formulation for this new approach in the setting of coronary stenting...
  28. ncbi Renal sympathetic denervation suppresses postapneic blood pressure rises and atrial fibrillation in a model for sleep apnea
    Dominik Linz
    Klinik fur Innere Medizin III, Universitatsklinikum des Saarlandes, 66421 Homburg Saar, Germany
    Hypertension 60:172-8. 2012
    ..Renal denervation displays antiarrhythmic effects by reducing NTP-induced AERP shortening and inhibits postapneic BP rises associated with obstructive events...
  29. ncbi Alterations in cholesterol homeostasis are associated with coronary heart disease in patients with aortic stenosis
    Oliver Weingärtner
    Klinik fur Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Universitatsklinikum des Saarlandes, Homburg Saar, Germany
    Coron Artery Dis 20:376-82. 2009
    ..Therefore, the aim of this study was to investigate differences in cholesterol metabolism in relation to vascular diseases in this subset of patients...
  30. ncbi Physical inactivity increases oxidative stress, endothelial dysfunction, and atherosclerosis
    Ulrich Laufs
    Klinik fur Innere Medizin III, niversitätsklinikum des Saarlandes, Homburg Saar, Germany
    Arterioscler Thromb Vasc Biol 25:809-14. 2005
    ..The underlying molecular mechanisms are incompletely understood. Reactive oxygen species (ROS) contribute to endothelial dysfunction and atherosclerosis. An important source of vascular ROS is the NADPH oxidase...
  31. ncbi Two year follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter
    Bruno Scheller
    Klinik fur Innere Medizin III, Universitatsklinikum des Saarlandes, Homburg, Saar, Germany
    Clin Res Cardiol 97:773-81. 2008
    ..We are presenting an extension of a previously published trial on the efficacy and safety of a paclitaxel-coated balloon in coronary ISR in a larger patient population and after a complete follow-up of 2 years...
  32. ncbi The peroxisome proliferator-activated receptor-gamma agonist pioglitazone increases number and function of endothelial progenitor cells in patients with coronary artery disease and normal glucose tolerance
    Christian Werner
    Klinik fur Innere Medizin III, Universitatsklinikum des Saarlandes, 66421 Homburg Saar, Germany
    Diabetes 56:2609-15. 2007
    ..The effect represents a potential regenerative mechanism in atherosclerosis and is observed in normoglycemic individuals with stable coronary artery disease...
  33. ncbi The renin inhibitor aliskiren upregulates pro-angiogenic cells and reduces atherogenesis in mice
    Janine Pöss
    Klinik fur Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Universitatsklinikum des Saarlandes, Kirrbergerstr, 66421, Homburg, Saar, Germany
    Basic Res Cardiol 105:725-35. 2010
    ..Aliskiren increased number and function of PAC in mice and prevented atherosclerotic lesion formation. The effects were observed independent of blood pressure lowering...
  34. ncbi Increased lysyl oxidase expression and collagen cross-linking during atrial fibrillation
    Oliver Adam
    Klinik fur Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Universitatsklinikum des Saarlandes, Homburg Saar, Germany
    J Mol Cell Cardiol 50:678-85. 2011
    ..In cardiac fibroblasts, Rac1 GTPase mediates upregulation of fibronectin via LOX and CTGF. Inhibition of this signaling pathway may therefore represent a target for the prevention of fibrotic atrial remodeling...
  35. ncbi Heart rate reduction by ivabradine reduces oxidative stress, improves endothelial function, and prevents atherosclerosis in apolipoprotein E-deficient mice
    Florian Custodis
    Klinik fur Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Universitatsklinikum des Saarlandes, 66424 Homburg Saar, Germany
    Circulation 117:2377-87. 2008
    ..We hypothesized that selective heart rate reduction may influence endothelial function and atherogenesis and tested the effects of the I(f) current inhibitor ivabradine in apolipoprotein E-deficient mice...
  36. ncbi Association of heart rate with microalbuminuria in cardiovascular risk patients: data from I-SEARCH
    Michael Bohm
    Klinik für Innere Medizin III Cardiology, Angiology and Intensive Care Medicine, University of the Saarland, Homburg Saar, Germany
    J Hypertens 26:18-25. 2008
    ..In patients in sinus rhythm (n = 18 900) the relationship between increased heart rate and the prevalence of MAU was analysed...
  37. ncbi Cognitive function in patients with decompensated heart failure: the Cognitive Impairment in Heart Failure (CogImpair-HF) study
    Ingrid Kindermann
    Universitatsklinikum des Saarlandes, Klinik für Innere Medizin III Kardiologie, Angiologie, Internistische Intensivmedizin, Kirrbergerstraße, Homburg Saar, Germany
    Eur J Heart Fail 14:404-13. 2012
    ..Cognitive function and psychological co-morbidities are associated with hospitalization, disability, and mortality...
  38. ncbi Interleukin-6 induces oxidative stress and endothelial dysfunction by overexpression of the angiotensin II type 1 receptor
    Sven Wassmann
    Medizinische Klinik und Poliklinik, Innere Medizin III, Universitatskliniken des Saarlandes, D 66421 Homburg Saar, Germany
    Circ Res 94:534-41. 2004
    ..This interaction of the proinflammatory cytokine IL-6 with the renin-angiotensin system may represent an important pathogenetic mechanism in the atherosclerotic process...
  39. ncbi Nebivolol, but not metoprolol, improves endothelial function of the corpus cavernosum in apolipoprotein e-knockout mice
    Magnus Baumhakel
    Klinik fur Innere Medizin III, Universitatsklinikum des Saarlandes, D 66421 Homburg Saar, Germany
    J Pharmacol Exp Ther 325:818-23. 2008
    ..These effects may be related to a reduction of ROS production, which is independent of heart rate reduction, because metoprolol did not increase endothelial function...
  40. ncbi Cardiorespiratory response to exercise after renal sympathetic denervation in patients with resistant hypertension
    Christian Ukena
    Klinik fur Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Universitatsklinikum des Saarlandes, Homburg Saar, Germany
    J Am Coll Cardiol 58:1176-82. 2011
    ..This study sought to investigate the effects of interventional renal sympathetic denervation (RD) on cardiorespiratory response to exercise...
  41. ncbi Short- and long-term effects of a novel paclitaxel coated stent in the porcine coronary model
    Bruno Scheller
    Klinik für Innere Medizin III Kardiologie, Angiologie, Internistische Intensivmedizin, Universitatsklinikum des Saarlandes, Homburg Saar, Germany
    Clin Res Cardiol 97:118-23. 2008
    ..The aim of the present animal studies was to evaluate the novel paclitaxel coated Coroflex. Please stent in the porcine coronary model...
  42. ncbi Heart rate reduction in cardiovascular disease and therapy
    Jan Christian Reil
    Klinik fur Innere Medizin III, Kardiologie, Angiologie und, Internistische Intensivmedizin, Universitatsklinikum des Saarlandes, Kirrberger Strasse, 66421, Homburg Saar, Germany
    Clin Res Cardiol 100:11-9. 2011
    ..Heart rate can be easily determined during physical examination of the patient and therefore allows a simple hint on prognosis and efficiency of therapy...
  43. ncbi Rac1-induced connective tissue growth factor regulates connexin 43 and N-cadherin expression in atrial fibrillation
    Oliver Adam
    Klinik fur Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Universitätsklinikum des Saarland, Homburg Saar, Germany
    J Am Coll Cardiol 55:469-80. 2010
    ..We studied the signal transduction of atrial structural remodeling that contributes to the pathogenesis of atrial fibrillation (AF)...
  44. ncbi Cardiomyocytes of noncardiac origin in myocardial biopsies of human transplanted hearts
    Patrick Muller
    Departments of Innere Medizin III, Universitat des Saarlandes, Homburg Saar, Germany
    Circulation 106:31-5. 2002
    ....
  45. ncbi Endothelial nitric oxide synthase of the bone marrow regulates myocardial hypertrophy, fibrosis, and angiogenesis
    Andrey Kazakov
    Klinik fur Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Universitatsklinikum des Saarlandes, 66424 Homburg Saar, Germany
    Cardiovasc Res 93:397-405. 2012
    ..We hypothesized that eNOS of the bone marrow (BM) affects cardiac remodelling during myocardial hypertrophy via the regulation of BM-derived vascular progenitor cells...
  46. ncbi Update on myocarditis
    Ingrid Kindermann
    Universitatsklinikum des Saarlandes, Klinik fur Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Kirrberger Strasse 1, Homburg Saar, Germany
    J Am Coll Cardiol 59:779-92. 2012
    ..Further investigations by controlled, randomized studies are needed to definitively determine their role in the treatment of myocarditis...
  47. ncbi Role of integrin-linked kinase for functional capacity of endothelial progenitor cells in patients with stable coronary artery disease
    Christian Werner
    Klinik für Innere Medizin III Kardiologie, Angiologie, Internistische Intensivmedizin, Universitatsklinikum des Saarlandes, 66421 Homburg Saar, Germany
    Biochem Biophys Res Commun 377:331-6. 2008
    ..Functionally, ILK is necessary and sufficient for SDF-1-triggered migration and adhesion in EPCs. These data extend current knowledge about the role of ILK in EPC biology and implicate ILK as a therapeutic target in CAD...
  48. ncbi Association of RhoGDIalpha with Rac1 GTPase mediates free radical production during myocardial hypertrophy
    Florian Custodis
    Klinik und Poliklinik für Innere Medizin III, Universitat des Saarlandes, Homburg Saar, Germany
    Cardiovasc Res 71:342-51. 2006
    ..NADPH oxidase is a major source of ROS production. The small GTPase Rac1 mediates the activation of NADPH oxidase; however, the mechanism of Rac1 activation is incompletely understood...
  49. ncbi Telmisartan inhibits beta2-integrin MAC-1 expression in human T-lymphocytes
    Andreas Link
    Klinik fur Innere Medizin III, Universitat des Saarlandes, Homburg Saar, Germany
    J Hypertens 24:1891-8. 2006
    ..Although pro-inflammatory properties of angiotensin II as well as anti-inflammatory effects of AT1 receptor antagonists are well known, the underlying mechanisms are poorly understood...
  50. ncbi Rapid immunomodulation by rosuvastatin in patients with acute coronary syndrome
    Andreas Link
    Klinik fur Innere Medizin III, Universitatsklinikum des Saarlandes, D 66421Homburg Saar, Germany
    Eur Heart J 27:2945-55. 2006
    ..It is unclear how rapidly the beneficial effects of statins occur in patients with ACS and whether these drug properties are related to lipid lowering...
  51. ncbi RAS blockade with ARB and ACE inhibitors: current perspective on rationale and patient selection
    Christian Werner
    Klinik für Innere Medizin III Kardiologie, Angiologie und Internistische Intensivmedizin, Universitatsklinikum des Saarlandes, Homburg Saar, Germany
    Clin Res Cardiol 97:418-31. 2008
    ....
  52. ncbi Biventricular versus conventional right ventricular stimulation for patients with standard pacing indication and left ventricular dysfunction: the Homburg Biventricular Pacing Evaluation (HOBIPACE)
    Michael Kindermann
    Klinik fur Innere Medizin III, Universitatsklinikum des Saarlandes, Homburg Saar, Germany
    J Am Coll Cardiol 47:1927-37. 2006
    ....
  53. ncbi Heart failure with normal left ventricular ejection fraction: what is the evidence?
    Michael Kindermann
    Klinik fur Innere Medizin III, Universitatsklinikum des Saarlandes, Homburg Saar, Germany
    Trends Cardiovasc Med 18:280-92. 2008
    ..In contrast to heart failure with reduced ejection fraction, large-scale randomized controlled drug trials for HFNEF are scarce and could not demonstrate mortality reduction so far...
  54. ncbi Images in cardiovascular medicine. Cardiac imaging in isolated noncompaction of ventricular myocardium
    Magnus Baumhakel
    Medizinische Klinik und Poliklinik, Innere Medizin III, Universitatskliniken des Saarlandes, Homburg Saar, Germany
    Circulation 106:e16-7. 2002
  55. ncbi Heart-rate reduction by If-channel inhibition with ivabradine restores collateral artery growth in hypercholesterolemic atherosclerosis
    Stephan H Schirmer
    Klinik für Innere Medizin III Kardiologie, Angiologie und Internistische Intensivmedizin, Universitatsklinikum des Saarlandes, Kirrberger Strase, Homburg Saar, Germany
    Eur Heart J 33:1223-31. 2012
    ..Collateral arteries protect tissue from ischaemia. Heart rate correlates with vascular events in patients with arterial obstructive disease. Here, we tested the effect of heart-rate reduction (HRR) on collateral artery growth...
  56. ncbi Beneficial association of β-blocker therapy on recovery from severe acute heart failure treatment: data from the Survival of Patients With Acute Heart Failure in Need of Intravenous Inotropic Support trial
    Michael Bohm
    Klinik fur Innere Medizin III, Universitatsklinikum des Saarlandes, Homburg Saar, Germany
    Crit Care Med 39:940-4. 2011
    ..The aim is to determine whether β-blocker use at study entry and/or at discharge has an impact on 31- and 180-day survival...
  57. ncbi The cardiac effects of prolonged vitamin B12 and folate deficiency in rats
    Omid Taban-Shomal
    Department of Clinical Chemistry and Laboratory Medicine, University Hospital of Saarland, 66421 Homburg Saar, Germany
    Cardiovasc Toxicol 9:95-102. 2009
    ..05), and tissue HCY (Co vs VitDef: 0.13 +/- 0.07 vs 0.07 +/- 0.04 micromol/g protein, P < 0.05) were lower in VitDef animals. Folate and vitamin B12 deficiency do not affect cardiac function and morphology...
  58. ncbi Prognostic electrocardiographic parameters in patients with suspected myocarditis
    Christian Ukena
    Klinik fur Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Universitatsklinikum des Saarlandes, Kirrbergerstraße, 66421 Homburg Saar, Germany
    Eur J Heart Fail 13:398-405. 2011
    ..The objective of this study was to investigate the prognostic value of electrocardiographic (ECG) parameters for outcome in patients acutely admitted with myocarditis without previous heart failure who underwent endomyocardial biopsy...
  59. ncbi Atrial fibrillation and heart rate independently correlate to microalbuminuria in hypertensive patients
    Michael Bohm
    Klinik für Innere Medizin III Kardiologie, Angiologie, Internistische Intensivmedizin, Universitat des Saarlandes, Kirrberger Strasse, 66424 Homburg Saar, Germany
    Eur Heart J 30:1364-71. 2009
    ..To investigate the relationship between microalbuminuria (MAU) and atrial fibrillation (AF) and to further evaluate whether the heart rate dependency of MAU in patients without AF is maintained in patients with a history of AF...
  60. ncbi Relationship between cholesterol synthesis and intestinal absorption is associated with cardiovascular risk
    Oliver Weingärtner
    Klinik fur Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Universitatsklinikum des Saarlandes, Kirrberger Strasse, Gebäude 40, D 66421 Homburg Saar, Germany
    Atherosclerosis 210:362-5. 2010
    ..Therefore, prospective clinical trials are needed to evaluate whether subjects with altered cholesterol homeostasis may benefit from treatment strategies that reduce cholesterol absorption in addition to statin treatment...
  61. ncbi Predictors of outcome in patients with suspected myocarditis
    Ingrid Kindermann
    Universitatsklinikum des Saarlandes, Klinik fur Innere Medizin III, Homburg Saar, Germany
    Circulation 118:639-48. 2008
    ..The objective of this study was to identify the prognostic indicators in patients with suspected myocarditis who underwent endomyocardial biopsy...
  62. ncbi Virus serology in patients with suspected myocarditis: utility or futility?
    Felix Mahfoud
    Klinik fur Innere Medizin III, Angiologie und Internistische Intensivmedizin, Universitatsklinikum des Saarlandes, Kirrberger Strasse 1, Homburg Saar, Germany
    Eur Heart J 32:897-903. 2011
    ..We determined prospectively the diagnostic value of virus serology in comparison with endomyocardial biopsy (EMB) including viral genome detection and immunohistochemistry in patients with clinically suspected myocarditis...
  63. ncbi Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study
    Felix Mahfoud
    Klinik fur Innere Medizin III, Universitatsklinikum des Saarlandes, Homburg Saar, Germany
    Circulation 123:1940-6. 2011
    ..We investigated the effect of catheter-based renal sympathetic denervation on glucose metabolism and blood pressure control in patients with resistant hypertension...
  64. ncbi Integrin-linked kinase is a central mediator in angiotensin II type 1- and chemokine receptor CXCR4 signaling in myocardial hypertrophy
    Stephanie I Bettink
    Klinik fur Innere Medizin III, Kardiologie, Angiologie, Internistische Intensivmedizin, Universitatsklinikum des Saarlandes, 66421 Homburg Saar, Germany
    Biochem Biophys Res Commun 397:208-13. 2010
    ..We conclude that in both SDF-1- and angiotensin II-triggered signaling, ILK is a central mediator of rac1-induced oxidative stress and myocardial hypertrophy...
  65. ncbi Running exercise of different duration and intensity: effect on endothelial progenitor cells in healthy subjects
    Ulrich Laufs
    Medizinische Klinik und Poliklinik der Universität des Saarlandes, Innere Medizin III, 66421 Homburg, Germany
    Eur J Cardiovasc Prev Rehabil 12:407-14. 2005
    ..Exercise is a central component of the primary prevention of vascular diseases. The effect of physical activity on circulating EPC in healthy individuals is not known...
  66. ncbi Beneficial effects of immediate stenting after thrombolysis in acute myocardial infarction
    Bruno Scheller
    Innere Medizin III, Universitat des Saarlandes, Homburg Saar, Germany
    J Am Coll Cardiol 42:634-41. 2003
    ..The Southwest German Interventional Study in Acute Myocardial Infarction (SIAM III) investigated potentially beneficial effects of immediate stenting after thrombolysis as opposed to a more conservative treatment regimen...
  67. ncbi HMG-CoA reductase inhibitors in chronic heart failure: potential mechanisms of benefit and risk
    Ulrich Laufs
    Klinik fur Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Universitatsklinikum des Saarlandes, Homburg Saar, Germany
    Drugs 66:145-54. 2006
    ....
  68. ncbi Endogenous activation of mitochondrial KATP channels protects human failing myocardium from hydroxyl radical-induced stunning
    Christoph Maack
    Medizinische Klinik und Poliklinik, Innere Medizin III Kardiologie Angiologie, Universitatskliniken des Saarlandes, Homburg Saar, Germany
    Circ Res 105:811-7. 2009
    ..Furthermore, although ATP-dependent K+ channels (K(ATP) channels) are implicated in myocardial protection during ischemia/reperfusion ("ischemic preconditioning"), their role in heart failure has hardly been elucidated...
  69. ncbi Carvedilol but not metoprolol reduces beta-adrenergic responsiveness after complete elimination from plasma in vivo
    Michael Kindermann
    Klinik fur Innere Medizin III, Universitatsklinikum des Saarlandes, Homburg Saar, Germany
    Circulation 109:3182-90. 2004
    ..Here, we determined the significance of this phenomenon on human beta-ARs in vitro and in vivo...
  70. ncbi Effect of atorvastatin 80 mg on endothelial cell function (forearm blood flow) in patients with pretreatment serum low-density lipoprotein cholesterol levels <130 mg/dl
    Sven Wassmann
    Medizinische Klinik und Poliklinik, Innere Medizin III, Universitatskliniken des Saarlandes, Homburg Saar, Germany
    Am J Cardiol 93:84-8. 2004
    ..Statin treatment improved hyperemic forearm blood flow and decreased serum markers of oxidative stress and inflammation...
  71. ncbi [From risk factors to symptomatic coronary artery disease. Update cardiology 2001/2002--part I]
    Roland Fries
    Medizinische Klinik und Poliklinik, Innere Medizin III, Kardiologie Angiologie, Universitatskliniken des Saarlandes, Hamburg Saar
    Med Klin (Munich) 98:218-25. 2003
    ....
  72. ncbi Heart rate contributes to the vascular effects of chronic mental stress: effects on endothelial function and ischemic brain injury in mice
    Florian Custodis
    Klinik fur Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Universitatsklinikum des Saarlandes, Kirrberger Strase, 66424 Homburg Saar, Germany
    Stroke 42:1742-9. 2011
    ..Vascular effects of mental stress are only partially understood. Therefore, we studied effects of chronic stress and heart rate (HR) on endothelial function and cerebral ischemia...
  73. ncbi Down-regulation of Rac-1 GTPase by Estrogen
    Ulrich Laufs
    Medizinische Klinik und Poliklinik, Innere Medizin III, Universitatskliniken des Saarlandes, 66421 Homburg Saar, Germany
    J Biol Chem 278:5956-62. 2003
    ..Rac1 GTPase gene-transcription and activity is regulated by 17 beta-estradiol, which may be an important molecular mechanism contributing to the cardiovascular effects of estrogens...
  74. ncbi Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis
    Ulrich Laufs
    Medizinische Klinik und Poliklinik der Universität des Saarlandes, Innere Medizin III, Homburg, Germany
    Circulation 109:220-6. 2004
    ..Bone marrow-derived endothelial progenitor cells (EPCs) are thought to exert beneficial effects on atherosclerosis, angiogenesis, and vascular repair...
  75. ncbi Partial agonist activity of bucindolol is dependent on the activation state of the human beta1-adrenergic receptor
    Christoph Maack
    Klinik und Poliklinik für Innere Medizin III, Universitat des Saarlandes, Homburg Saar, Germany
    Circulation 108:348-53. 2003
    ....
  76. ncbi Inhibition of diet-induced atherosclerosis and endothelial dysfunction in apolipoprotein E/angiotensin II type 1A receptor double-knockout mice
    Sven Wassmann
    Klinik fur Innere Medizin III, Universitatsklinikum des Saarlandes, Homburg Saar, Germany
    Circulation 110:3062-7. 2004
    ..Angiotensin II type 1 (AT1) receptor activation is potentially involved in the multifactorial pathogenesis of atherosclerosis...
  77. ncbi Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation
    Bruno Scheller
    Internal Medicine III Cardiology Angiology, University of Saarland, Homburg Saar, Germany
    J Am Coll Cardiol 42:1415-20. 2003
    ..The present study was designed to test the efficacy of paclitaxel added to the contrast agent iopromide in the prevention of restenosis...
  78. ncbi Phosphodiesterase 4 inhibition but not beta-adrenergic stimulation suppresses tumor necrosis factor-alpha release in peripheral blood mononuclear cells in septic shock
    Andreas Link
    Klinik fur Innere Medizin III, Universitat des Saarlandes, 66421 Homburg Saar, Germany
    Crit Care 12:R159. 2008
    ....
  79. ncbi Telmisartan prevents cardiovascular events in a broad group of at-risk patients
    Magnus Baumhakel
    University Hospital of the Saarland, Department of Cardiology, Homburg Saar, Germany
    Expert Opin Pharmacother 10:3113-7. 2009
    ..In these patients who are intolerant to ACE-Is or who do not achieve blood pressure control, the ARB with the best evidence for secondary prevention is telmisartan according to the results of the ONTARGET trial...
  80. ncbi Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis
    Bruno Scheller
    Department of Internal Medicine III Cardiology Angiology, University of Saarland, Homburg Saar, Germany
    Circulation 110:810-4. 2004
    ..The aim of the present study was to evaluate a novel method of local drug delivery based on angioplasty balloons...
  81. ncbi Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury
    Nikos Werner
    Klinik und Poliklinik, Innere Medizin III, , 66421 Homburg/Saar, Germany
    Circ Res 93:e17-24. 2003
    ..The full text of this article is available online at http://www.circresaha.org...
  82. ncbi Sildenafil in the treatment of Raynaud's phenomenon resistant to vasodilatory therapy
    Roland Fries
    Klinik für Innere Medizin III Kardiologie, Angiologie, Internistische Intensivmedizin, Universitatsklinikum des Saarlandes, Homburg Saar, Germany
    Circulation 112:2980-5. 2005
    ..Vasodilatory therapy of Raynaud's phenomenon represents a difficult clinical problem because treatment often remains inefficient and may be not tolerated because of side effects...
  83. ncbi Pressure-induced cardiac overload induces upregulation of endothelial and myocardial progenitor cells
    Patrick Muller
    Klinik fur Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Universitatsklinikum des Saarlandes, 66424 Homburg Saar, Germany
    Cardiovasc Res 77:151-9. 2008
    ..Bone-marrow-derived progenitor cells have been shown to contribute to endothelial homeostasis, repair, and new blood vessel formation. We therefore studied the effects of pressure overload on angiogenesis and progenitor cells...
  84. ncbi Angiotensin II type 1 receptor antagonism improves hypercholesterolemia-associated endothelial dysfunction
    Sven Wassmann
    Medizinische Klinik und Poliklinik, Innere Medizin III, Universitatskliniken des Saarlandes, Homburg Saar, Germany
    Arterioscler Thromb Vasc Biol 22:1208-12. 2002
    ..Hypercholesterolemia-induced angiotensin II type 1 (AT1) receptor overexpression is thought to be a key event in the development of endothelial dysfunction...
  85. ncbi Rapid effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition on coronary endothelial function
    Sven Wassmann
    Medizinische Klinik und Poliklinik, Innere Medizin III, , D-66421 Homburg/Saar, Germany
    Circ Res 93:e98-103. 2003
    ..Statin treatment improves endothelium-dependent coronary vasomotion within 24 hours in the absence of significant cholesterol reduction. The full text of this article is available online at http://www.circresaha.org...
  86. ncbi Impact of HMG CoA reductase inhibition on small GTPases in the heart
    Ulrich Laufs
    Medizinische Klinik und Poliklinik der Universität des Saarlandes, Innere Medizin III, 66421 Homburg Saar, Germany
    Cardiovasc Res 53:911-20. 2002
    ..Therefore, it was tested if these drugs inhibit Rac1 and RhoA activity in cardiomyocytes and, thereby, prevent angiotensin II-mediated expression of atrial natriuretic factor (ANF) and myosin light chain (MLC)-2 in the heart...
  87. ncbi Oxygen free radical release in human failing myocardium is associated with increased activity of rac1-GTPase and represents a target for statin treatment
    Christoph Maack
    , , Homburg/Saar, Germany
    Circulation 108:1567-74. 2003
    ..Oral statin treatment inhibits myocardial rac1-GTPase activity. These data suggest that extrahepatic effects of statins can be observed in humans and may be beneficial for patients with chronic heart failure...
  88. ncbi Effect of ramipril and furosemide treatment on interstitial remodeling in post-infarction heart failure rat hearts
    Ute Seeland
    Med Univ Klinik und Poliklinik der Universität des Saarlandes, Innere Medizin III Kardiologie und Angiologie, 66421 Homburg Saar, Germany
    J Mol Cell Cardiol 34:151-63. 2002
    ..Furosemide did not show the beneficial effects of ramipril on ECM remodeling but did not worsen LV function. Positive effects of furosemide treatment alone on LV remodeling and function were not observed...
  89. ncbi Hotline update of clinical trials and registries presented at the German Cardiac Society Meeting 2007: 2L-Registry, Kardio-Pro, EVER, AFFECT, VTACH, ARTS II, OPTAMI, PEPCAD I, PEPCAD II, GERSHWIN, SPICE, FIX-CHF and CREDIT
    Stephan Rosenkranz
    Universitat zu Koln, Klinik fur Innere Medizin III, Joseph Stelzmann Str 9, 50924 Köln, Germany
    Clin Res Cardiol 96:457-68. 2007
    ..These comprehensive summaries should provide the readers with the most recent data on diagnostic and therapeutic developments in cardiovascular medicine...
  90. ncbi ACE inhibition in secondary prevention: are the results controversial?
    Erik B Friedrich
    Klinik fur Innere Medizin III, Universitatsklinikum des Saarlandes, Kirrberger Strasse, 66421 Homburg Saar, Germany
    Clin Res Cardiol 95:61-7. 2006
    ..Further studies are needed to try to resolve this issue. In the meantime, the overwhelming data still support the use of ACE inhibitors in patients with coronary artery disease with preserved left ventricular function...
  91. ncbi Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter
    Bruno Scheller
    Universitatsklinikum des Saarlandes, Homburg Saar, Germany
    N Engl J Med 355:2113-24. 2006
    ..Treatment of coronary in-stent restenosis is hampered by a high incidence of recurrent in-stent restenosis. We assessed the efficacy and safety of a paclitaxel-coated balloon in this setting...
  92. ncbi Effects of sildenafil (viagra) on human myocardial contractility, in vitro arrhythmias, and tension of internal mammaria arteries and saphenous veins
    Bodo Cremers
    Medizinische Klinik und Poliklinik, Innere Medizin III, Chirurgische Klinik und Poliklinik, Abteilung Thorax-und Herz, Homburg, Germany
    J Cardiovasc Pharmacol 41:734-43. 2003
    ..4 +/- 10.1%, n = 4, P < 0.02) as well as in veins (73.5 +/- 6.3%, n = 6, P < 0.02). Sildenafil exerts potent vasodilatory actions but has no direct influence on human myocardial contractility or proarrhythmic effects in vitro...
  93. ncbi Raloxifene improves endothelial dysfunction in hypertension by reduced oxidative stress and enhanced nitric oxide production
    Sven Wassmann
    Medizinische Klinik und Poliklinik, Innere Medizin III, , Homburg/Saar, Germany
    Circulation 105:2083-91. 2002
    ..These vascular effects cause a profound blood pressure reduction and lead to decreased vascular damage in male spontaneously hypertensive rats...
  94. ncbi Rosuvastatin, a new HMG-CoA reductase inhibitor, upregulates endothelial nitric oxide synthase and protects from ischemic stroke in mice
    Ulrich Laufs
    , Innere Medizin III, 66421 Homburg, Germany
    Brain Res 942:23-30. 2002
    ..The effects are independent of changes in cholesterol levels and are equivalent or even superior to the protective effects by simvastatin and atorvastatin in this animal model...
  95. ncbi Bone marrow-derived progenitor cells modulate vascular reendothelialization and neointimal formation: effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition
    Nikos Werner
    Medizinische Klinik und Poliklinik, Innere Medizin III, , Homburg/Saar, Germany
    Arterioscler Thromb Vasc Biol 22:1567-72. 2002
    ..These findings may help to establish novel pathophysiological concepts and therapeutic strategies in the treatment of various cardiovascular diseases...
  96. ncbi AT1 receptor antagonism improves endothelial dysfunction in postmenopausal women
    Kerstin Wassmann
    , , Homburg/Saar, Germany
    Maturitas 53:176-83. 2006
    ..AT1 receptor antagonism improves vascular function in postmenopausal women without HRT. Thus, AT1 receptor blockade may resemble an efficient approach for the prevention of vascular dysfunction in estrogen-deficient women...
  97. ncbi Cellular antioxidant effects of atorvastatin in vitro and in vivo
    Sven Wassmann
    Medizinische Klinik und Poliklinik-Innere Medizin III, , Homburg/Saar, Germany
    Arterioscler Thromb Vasc Biol 22:300-5. 2002
    ..These effects of atorvastatin may contribute to the vasoprotective effects of statins...
  98. ncbi Angiotensin receptor blockers versus angiotensin-converting enzyme inhibitors: where do we stand now?
    Michael Bohm
    Department of Internal Medicine III, Cardiology Angiology and Intensive Cardiac Medicine, University of Saarland, Homburg Saar, Germany
    Am J Cardiol 100:38J-44J. 2007
    ....
  99. ncbi [Pathophysiology and differential diagnosis of dyspnea]
    Oliver Weingärtner
    Medizinische Universitätsklinik und Poliklinik, Innere Medizin III, Homburg Saar
    Herz 29:595-601. 2004
    ..This article attempts to summarize the current understanding of dyspnea, explain the essential underlying pathophysiological mechanisms, discuss the broad differential diagnosis, and suggest diagnostic algorithms...
  100. ncbi Contrast-enhanced cardiovascular magnetic resonance imaging
    Gunther Schneider
    Department of Diagnostic Radiology, University Hospital Saarland, Homburg Saar, Germany
    Top Magn Reson Imaging 14:386-402. 2003
    ....
  101. ncbi Acute cardiac tolerance of current contrast media and the new taxane protaxel using iopromide as carrier during porcine coronary angiography and stenting
    Bruno Scheller
    Internal Medicine III Cardiology, University of Saarland, Homburg Saar, Germany
    Invest Radiol 37:29-34. 2002
    ..The aim of this study was to comparatively evaluate the cardiovascular tolerability of iopromide, ioxaglate, and iosmin, and of a novel taxane protaxel, dissolved in iopromide, as a carrier, by coronary angiography and stenting...